Nanotechnology Now

Our NanoNews Digest Sponsors







Heifer International

Wikipedia Affiliate Button


Home > Press > Arrowhead to Present at Series of Upcoming Scientific Conferences: Data Highlights Results Demonstrating Effectiveness of DPC siRNA Delivery System and Path to the Clinic for siRNA-based Hepatitis B Treatment

Abstract:
Arrowhead Research Corporation (NASDAQ:ARWR) today announced that senior management will present data for its Dynamic PolyConjugateTM (DPC) delivery platform for siRNA delivery including its RNAi therapeutic candidate for the treatment of hepatitis B virus (HBV) at several upcoming scientific conferences.

Arrowhead to Present at Series of Upcoming Scientific Conferences: Data Highlights Results Demonstrating Effectiveness of DPC siRNA Delivery System and Path to the Clinic for siRNA-based Hepatitis B Treatment

Pasadena, CA | Posted on May 3rd, 2012

"Arrowhead's DPC delivery system and the associated HBV program have been under development for several years at our Madison site, first as Mirus Bio and then as a subsidiary of Roche. It's been several years since data regarding the programs have been presented to the scientific community at large. We are looking forward to unveiling advanced and exciting results in these forums and to related publications later this year," said Dr. Christopher Anzalone, Arrowhead's CEO & President.

Scheduled conference presentations are as follows:

European Foundation for Clinical Nanomedicine (CLINAM)
Basel, Switzerland

An oral presentation titled, "DPC Technology for Safe and Effective siRNA Delivery," will be presented by Dr. David Lewis, Vice President, Biology and Site Head on May 9, 2012 at 8:35 AM CEST

TIDES: Oligonucleotide & PeptideŽ Research, Technology & Product Development

Las Vegas, NV, May 20-23

A poster titled, "Liver-targeted and reversibly masked-polycation co-delivery improves cholesterol-conjugated siRNA efficacy" will be presented by Dr. Darren Wakefield, Senior Scientist

RNA Society Annual Meeting
Ann Arbor, MI

A poster titled, "Effective RNAi Therapeutic to Treat Chronic Hepatitis B Virus Infection." will be presented by Dr. Christine Wooddell, Senior Scientist

RNAi Research & Therapeutics Conference

Boston, MA, May 29-June 3

An oral presentation titled, "The Development of Dynamic Poly Conjugates" will be presented by Dr. David Rozema, Vice President, Chemistry, on May 30, 2012 at 10:30 AM ET

RNAi & Nanotechnology Conference

London, UK

An oral presentation titled, "DPC Technology for siRNA Delivery: from rodents to primates" will be presented by Dr. David Lewis on June 11, 2012 11:40 AM GMT

International Congress on Infectious Diseases

Bangkok, Thailand

An oral presentation in the session New Developments in Viral Diseases: "RNAi therapeutics for the treatment of chronic hepatitis B virus infection" will be presented by Dr. David Lewis on Friday, June 15, 2012, 3:45 PMICT

Arrowhead published a white paper providing an overview of its proprietary DPC technology for safe and effective delivery of siRNA. This white paper can be found on the Arrowhead website at www.arrowheadresearch.com/pdf/Arrowhead-Research-Corporation_-_DPC-Technology-White-Paper-November2011.pdf

Arrowhead has also released a white paper describing the health problem posed by the hepatitis B virus (HBV), the substantial unmet need for chronic HBV infected patients, and how Arrowhead's Dynamic Polyconjugate (DPC) enabled RNAi therapeutic in development could potentially address deficiencies of current treatment options. This white paper can be found on the Arrowhead website at www.arrowheadresearch.com/pdf/whitepaper-hbv-3-7-12.pdf

####

About Arrowhead Research Corporation
Arrowhead Research Corporation is a clinical stage nanomedicine company developing innovative therapies at the interface of biology and nanoengineering. Arrowhead's world-class capabilities and intellectual property covering nucleic acid delivery, siRNA chemistry, and tissue targeting allow it to design and develop therapeutic agents for a wide range of diseases. The company's lead products include CALAA-01, an oncology drug candidate based on the gene silencing RNA interference (RNAi) mechanism, and AdipotideTM, an anti-obesity peptide that targets and kills the blood vessels that feed white adipose tissue. Arrowhead is leveraging its proprietary Dynamic PolyConjugateTM (DPC), Liposomal Nanoparticle (LNP), and RONDELTM delivery platforms to support its own pipeline of preclinical and clinical candidates and to secure external partnerships and collaborations with biotech and pharmaceutical companies.

For more information please visit www.arrowheadresearch.com, or follow us on Twitter @ArrowRes. To be added to the Company's email list to receive news directly, please send an email to

For more information, please click here

Contacts:
Investor Relations Contact:
Michael Levitan
The Trout Group, LLC
646-378-2920

Copyright © Arrowhead Research Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nano-needles for cells May 25th, 2013

How do cold ions slide May 24th, 2013

Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013

Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013

Nanomedicine

Nano-needles for cells May 25th, 2013

UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013

Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013

How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013

Announcements

Nano-needles for cells May 25th, 2013

How do cold ions slide May 24th, 2013

Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013

Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013

Events/Classes

Conference Scheduled June 5-7 on Safe Use of Nanotechnology in Environmental Remediation May 23rd, 2013

Precision Positioning Systems go Nano: New Miniaturized Piezo-Motor Driven Nanopositioning Stage by PI May 22nd, 2013

Bacterial spare parts filter antibiotic residue from groundwater May 22nd, 2013

Xmark Media announces the 2013 Vacuum Expo & Vacuum Symposium, Ricoh Arena - Coventry 16-17 October May 21st, 2013

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project








abbigliamento uomo
Computer Accessories
© Copyright 1999-2013 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE